Can SBRT Improve Immunotherapy Outcomes in Metastatic NSCLC?

A new study examined whether stereotactic body radiotherapy prior to pembrolizumab improved response rate in lung cancer patients.

Source: CancerNetwork - July 12, 2019 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news